ARCHIVES

Why Four? NCI Official Challenged To Explain Rational For Proposed Number Of Groups

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

Weight An Indicator For Risk Of Developing Myeloma

August 31, 2007

In Brief: Friedman Leads FDA During Search; Mead Retires From NCI; Freireich Honored

March 14, 1997

Clinical Biomarker Discovery Initiative would speed progress in early detection and measurement of response to therapy, Leland Hartwell tells NCI.

November 12, 2004

NCI Summarizes AIDS Virus Developments

May 4, 1984

NCI Proposes Inviting Academic Labs To Submit New Therapies For Development

January 23, 1998

DeVita Changes Mind On OSP Phase Out Reasons, But Presses for “Internalizing” Coordinating Portfolio

January 1, 1988